Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (79)

• Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis via openalex
• Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis via openalex
• An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells via openalex
• Classification of endometriotic implants by morphologic appearance and capacity to synthesize prostaglandin F via openalex
• Cyclooxygenase-2 Regulates Survival, Migration, and Invasion of Human Endometriotic Cells through Multiple Mechanisms via openalex
• Endometriosis via openalex
• Endometriosis: disease pathophysiology and the role of prostaglandins via openalex
• Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions via openalex
• Gene expression profiles and functional characterization of human immortalized endometriotic epithelial and stromal cells via openalex
• Identification of an Invasive, N-Cadherin-Expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model via openalex
• Induction of peritoneal endometriosis in nude mice with use of human immortalized endometriosis epithelial and stromal cells: a potential experimental tool to study molecular pathogenesis of endometriosis in humans via openalex
• Inhibition of CD36-Dependent Phagocytosis by Prostaglandin E2 Contributes to the Development of Endometriosis via openalex
• Menstrual bleeding from an endometriotic lesion via openalex
• On the Vasculature of Ectopic Endometrium with Decidual Reaction via openalex
• Pathogenesis and pathophysiology of endometriosis via openalex
• Prolonged stimulation with tumor necrosis factor-α induced partial methylation at PR-B promoter in immortalized epithelial-like endometriotic cells via openalex
• Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Endometriosis via openalex
• Promoter Methylation Regulates Estrogen Receptor 2 in Human Endometrium and Endometriosis1 via openalex
• Prostaglandin E ₂ : the master of endometriosis? via openalex
• Prostaglandin receptor signalling and function in human endometrial pathology via openalex
• Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis via openalex
• Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Induces Apoptosis of Human Endometriotic Cells through Suppression of ERK1/2, AKT, NFκB, and β-Catenin Pathways and Activation of Intrinsic Apoptotic Mechanisms via openalex
• Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Induces Apoptosis of Human Endometriotic Cells through Suppression of ERK1/2, AKT, NFκB and β-CATENIN Pathways and Activation of Intrinsic Apoptotic Mechanisms via openalex
• Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Inhibits Adhesion of Human Endometriotic Epithelial and Stromal Cells Through Suppression of Integrin-Mediated Mechanisms1 via openalex
• Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases via openalex
• Suppression of IL-1β-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells via openalex
• The knockdown of progesterone receptor isoform B (PR-B) promotes proliferation in immortalized endometrial stromal cells via openalex
• Three-dimensional architectures of peritoneal endometriosis via openalex
• Transcriptional Activation of Steroidogenic Factor-1 by Hypomethylation of the 5′ CpG Island in Endometriosis via openalex
• Trichostatin A, a Histone Deacetylase Inhibitor, Attenuates Invasiveness and Reactivates E-Cadherin Expression in Immortalized Endometriotic Cells via openalex
• W2133969720 via openalex
• W2138341116 via openalex
• W2148558073 via openalex
• W2152497434 via openalex
• W2153278559 via openalex
• W2154719999 via openalex
• W2159854469 via openalex
• W2160829078 via openalex
• W2161774786 via openalex
• W2164385268 via openalex
• W2168991217 via openalex
• W2258579859 via openalex
• W2291960606 via openalex
• W2800526221 via openalex
• W2801944549 via openalex
• W4211081176 via openalex
• W4233036449 via openalex
• W4237504024 via openalex
• W170550312 via openalex
• W4293247451 via openalex
• W1969169755 via openalex
• W1970690912 via openalex
• W1978893041 via openalex
• W1981263394 via openalex
• W1991266606 via openalex
• W1991667131 via openalex
• W1992902970 via openalex
• W2001277555 via openalex
• W2009858080 via openalex
• W2019474060 via openalex
• W2029484950 via openalex
• W2029686419 via openalex
• W2040095832 via openalex
• W2042336817 via openalex
• W2043721269 via openalex
• W2051553283 via openalex
• W2053421436 via openalex
• W2067837272 via openalex
• W2074252380 via openalex
• W2092835614 via openalex
• W2093865824 via openalex
• W2100325414 via openalex
• W2108787980 via openalex
• W2113753611 via openalex
• W2121612337 via openalex
• W2123552387 via openalex
• W2124419959 via openalex
• W2128635872 via openalex
• W2130808015 via openalex

Cited by (36)

• The "double-edged sword" effect of non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of endometriosis (EMS) 2025
• Endometriosis: A new perspective on epigenetics and oxidative stress 2025
• Molecular Basis of Impaired Decidualization in the Eutopic Endometrium of Endometriosis Patients 2025
• Etiologies of endometriosis and model systems: is there a risk of a tunnel vision? 2025
• Epigenetic Dysregulation in Endometriosis: Implications for Pathophysiology and Therapeutics 2023
• Decreased Expression of EZH2 in Granulosa Cells Contributes to Endometriosis-Associated Infertility by Targeting IL-1R2 2022
• Endometriosis: A Disease with Few Direct Treatment Options 2022
• Molecular dysregulations underlying the pathogenesis of endometriosis 2021
• Changing prostaglandin E2 (PGE₂) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE₂ receptor EP2 and EP4 2021
• Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis 2021
• Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling 2021
• TET1 may contribute to hypoxia-induced epithelial to mesenchymal transition of endometrial epithelial cells in endometriosis 2020
• Establishment of endometriotic models: the past and future 2020
• Peer Review #1 of "TET1 may contribute to hypoxia-induced epithelial to mesenchymal transition of endometrial epithelial cells in endometriosis (v0.2)" 2020
• Peer Review #3 of "TET1 may contribute to hypoxia-induced epithelial to mesenchymal transition of endometrial epithelial cells in endometriosis (v0.2)" 2020
• Peer Review #1 of "TET1 may contribute to hypoxia-induced epithelial to mesenchymal transition of endometrial epithelial cells in endometriosis (v0.1)" 2020
• Peer Review #3 of "TET1 may contribute to hypoxia-induced epithelial to mesenchymal transition of endometrial epithelial cells in endometriosis (v0.1)" 2020
• Peer Review #2 of "TET1 may contribute to hypoxia-induced epithelial to mesenchymal transition of endometrial epithelial cells in endometriosis (v0.2)" 2020
• Peer Review #2 of "TET1 may contribute to hypoxia-induced epithelial to mesenchymal transition of endometrial epithelial cells in endometriosis (v0.1)" 2020
• Genetic, Epigenetic, and Steroidogenic Modulation Mechanisms in Endometriosis 2020
• The value of the assesment of ARID1A expression, prostaglandin E2 synthase and the prostaglandin E2 receptor in patientswith genital endometriosis 2019
• The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights 2019
• Aldo-keto reductase 1C3—Assessment as a new target for the treatment of endometriosis 2019
• Hypoxia: The force of endometriosis 2019
• Decreased Expression of HOXA10 May Activate the Autophagic Process in Ovarian Endometriosis 2018
• Endometriosis and Epigenetics: What do we Know? 2018
• Translational Aspects of the Endometriosis Epigenome 2018
• Epigenetic Dynamics of HOXA10 Gene in Infertile Women With Endometriosis 2018
• Estrogen Biosynthesis and Its Regulation in Endometriosis 2017
• The effect of prostaglandin E2 receptor (PTGER2) activation on growth factor expression and cell proliferation in bovine endometrial explants 2017
• Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis 2017
• Epigenetic regulation of the pathological process in endometriosis 2017
• Endométriose : physiopathologie, facteurs génétiques et diagnostic clinique 2017
• DNA methylation in endometriosis (Review) 2016
• Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis 2016
• Molecular Biology of Endometriosis 2016

Source provenance

europepmc

last seen: 2026-06-04T01:30:01.192114+00:00

openalex

last seen: 2026-06-04T00:00:01.174412+00:00

pubmed

last seen: 2026-05-13T22:17:58.238279+00:00